the RIBESC study Researching the Impact on Biological Endpoints in Smoking Cessation von Philip Morris Products S.A.
the RIBESC study Researching the Impact on Biological Endpoints in Smoking Cessation
Auszug vom 20.03.2015
Konsumstrasse 16A
3007 Bern CH